SCHEMBL184898

SCHEMBL184898

C=C(CC[Si](C)(Cl)Cl)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.46
MAOB P27338 6/20 0.46
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MAPT P10636 2/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
EGFR P00533 1/20 0.33
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8383505 0.84 MAOA (0.44) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL2368282 0.77 MAOA (0.38) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL7990104 0.76 MAOA (0.56) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL3747872 0.76 MAOA (0.48) MAOAMAOBMAPTALDH1A1MAPK1
SCHEMBL886910 0.76 MAOA (0.40) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL2367611 0.74 MAOA (0.36) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL2367649 0.74 MAOA (0.36) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL2368067 0.73 MAOA (0.35) MAOAMAOBSLC6A4SLC6A3MAPT
SCHEMBL78217 0.73 CES2 (0.52) MAOAMAOBLMNA
SCHEMBL810101 0.73 MAOA (0.48) MAOAMAOBSLC6A4SLC6A3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054095-B1 MEDICAL DEVICES HAVING IMPROVED MECHANICAL PERFORMANCE BOSTON SCIENT LTD (BM) 2016-08-24 EP disclosed
US-8367096-B2 Polymers having covalently bound therapeutic agents BOSTON SCIENTIFIC SCIMED, INC. (US) 2013-02-05 US disclosed
US-8092821-B2 Medical devices having polymeric regions with improved adhesion BOSTON SCIENTIFIC SCIMED, INC. (US) 2012-01-10 US disclosed
EP-2400998-A2 MEDICAL DEVICES HAVING IMPROVED MECHANICAL PERFORMANCE Boston Scientific Scimed, Inc. (US) 2012-01-04 EP disclosed
EP-2054100-B1 MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH IMPROVED ADHESION BOSTON SCIENT LTD (BB) 2011-03-23 EP disclosed
US-7897170-B2 Medical devices having improved mechanical performance BOSTON SCIENTIFIC SCIMED, INC. (US) 2011-03-01 US disclosed
US-7897171-B2 Medical devices having improved mechanical performance BOSTON SCIENTIFIC SCIMED, INC. (US) 2011-03-01 US disclosed
WO-2010099260-A2 MEDICAL DEVICES HAVING IMPROVED MECHANICAL PERFORMANCE BOSTON SCIENTIFIC SCIMED, INC. (US) 2010-09-02 WO disclosed
US-20090186067-A1 MEDICAL DEVICES HAVING IMPROVED MECHANICAL PERFORMANCE BOSTON SCIENTIFIC SCIMED, INC. (US) 2009-07-23 US disclosed
EP-2054100-A2 MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH IMPROVED ADHESION Boston Scientific Scimed, Inc. (US) 2009-05-06 EP disclosed
WO-2008027107-A2 MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH IMPROVED ADHESION BOSTON SCIENTIFIC SCIMED, INC. (US) 2008-03-06 WO disclosed
US-20080051541-A1 Medical devices having improved mechanical performance BOSTON SCIENTIFIC SCIMED, INC. 2008-02-28 US disclosed
US-20080051542-A1 Medical devices having polymeric regions with improved adhesion STRICKLER FREDERICK H 2008-02-28 US disclosed
WO-2008024510-A2 MEDICAL DEVICES HAVING IMPROVED MECHANICAL PERFORMANCE BOSTON SCIENTIFIC SCIMED, INC. (US) 2008-02-28 WO disclosed
US-20070020308-A1 Polymers having covalently bound therapeutic agents BOSTON SCIENTIFIC SCIMED, INC. 2007-01-25 US disclosed
WO-2007012013-A2 POLYMER CONJUGATES TO THERAPEUTIC AGENTS VIA AN SI-N AND/OR AN SI-O LINKAGE BOSTON SCIENTIFIC SCIMED, INC. (US) 2007-01-25 WO disclosed
US-6469115-B1 ROOM TEMPERATURE VULCANIZABLE POLYISOBUTYLENE POLYMER HAVING HYDROLYZABLE SILYL- FUNCTIONAL GROUPS POSITIONED AT OR NEAR MOLECULAR CHAIN ENDS DOW CORNING CORPORATION 2002-10-22 US disclosed
WO-2002028924-A1 SILYL-FUNCTIONAL PSEUDO-TELECHELIC POLYISOBUTYLENE TERPOLYMERS DOW CORNING CORPORATION (US) 2002-04-11 WO disclosed
WO-2001087999-A2 VIRTUALLY TELECHELIC SILYL-FUNCTIONAL POLYISOBUTYLENE DOW CORNING CORPORATION (US) 2001-11-22 WO disclosed
US-6268451-B1 POLYMERS OF ISOBUTYLENE, ISOPRENYLPHENYL AND VINYLPHENYL WITH SILYLALKYL GROUPS WITH SOLVENTS UNIVERSITY OF MASSACHUSETTS LOWELL 2001-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186067-A1 MEDICAL DEVICES HAVING IMPROVED MECHANICAL PERFORMANCE PIGS, TNNI3, TNNC1 MAOA 3632/4885MAOB 2371/4885SLC6A4 3631/4885
US-20070020308-A1 Polymers having covalently bound therapeutic agents CD44, CD47, PAICS MAOA 2239/4885MAOB 2639/4885SLC6A4 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.